Clinical trial
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00028600 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00028600 |
|---|---|
| Title | Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma |
| Official title | Autologous Followed By Non-Myeloablative Allogeneic Transplant For Multiple Myeloma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Plasma Cell Neoplasm |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, CD34+ cells, cyclophosphamide, fludarabine phosphate, melphalan, methotrexate, tacrolimus |
| Enrollment | 60 |
| Start date | Nov 1, 2001 |
| Primary completion | Jun 1, 2006 |
| Completion | Feb 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 4, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: